MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Diabetes: Medtronic wins clearance for next-gen clinical continuous glucose monitor | Regulatory Roundup

Diabetes: Medtronic wins clearance for next-gen clinical continuous glucose monitor | Regulatory Roundup

By

Medtronic logo

Medtronic Inc. (NYSE:MDT) won FDA clearance for its next generation iPro2 Professional continuous glucose monitor.

The iPro2 Professional is a clinician-owned device that collects glucose data from a sensor inserted into a patient’s skin.

The device tracks the patient’s glucose levels for 3 days, collecting data as many as 288 times each day. The information may provide insight into how diet, medication and daily activities affect a patient’s glucose levels.

"I find it particularly helpful in identifying repeated glucose lows at night and glucose highs after meals," University Diabetes & Endocrine Consultants’ Dr. David Huffman said in prepared remarks. "I am one doctor in a busy office, but the advances with iPro2 will make Professional CGM accessible to more patients who need it. I see that as better medicine."

Professional CGM is ideal for patients with Type I or Type II diabetes who have are persistently unaware of extreme highs and lows in their glucose levels, according to a published consensus from the American Assn. of Clinical Endocrinologists. The clinician-led process was also recommended for pregnant women and youth with Type I diabetes.

Proper glucose control may help patients avoid complications associated with diabetes, including blindness, kidney failure, amputation, impotence and heart disease, according to a press release.

"CGM adoption is on the rise," Medtronic VP and general manager for the continuous glucose monitoring business Greg Meehan said in prepared remarks. "We believe the combination of improved reimbursement for both clinicians and patients, increased clinical evidence as seen in the Medtronic STAR 3 and JDRF trials, as well as ongoing product advancements, are moving CGM devices toward the standard of care for diabetes management."

Regulatory Roundup

  • Medtronic wins FDA nod for AdaptiveStim neurostimulator
    Medtronic announced approval of its AdaptiveStim with RestoreSensor neurostimulation system, the first and only chronic pain treatment that harnesses motion sensor technology found in smart phones and computer gaming systems to provide effective pain relief and convenience by automatically adapting stimulation levels.
    Read more

  • IntriCon lands 510(k) for cardiac diagnostic monitor
    IntriCon Corporation (NSDQ: IIN), developer of miniature and micro-miniature body-worn devices, received 510(k) clearance for its Sirona Event and Holter Recorder, the company’s second-generation cardiac diagnostic monitoring device, allowing physicians to monitor patient cardiac events remotely .
    Read more

  • SonoSite gets green light for Edge ultrasound system
    SonoSite Inc. (NSDQ:SONO) received FDA 510(k) clearance for its fifth-generation Edge ultrasound system.
    Read more

  • Staar Surgical wins CE mark for intraocular lens
    Staar Surgical Co., which designs, develops, manufactures and markets implantable lenses for the eye, received CE Mark approval in the European Union for its nanoFLEX Toric Collamer Single Piece intraocular lens.
    Read more

  • Vascular Designs lands regulatory wins for sideways perfusion catheter
    The IsoFlow Infusion Catheter, from Vascular Designs Inc.,  received CE Mark approval for use in Europe and Canada.
    Read more

  • Neovasc touts CE Mark for angina therapy
    Neovasc Inc. (NYSE: NVC) received CE mark approval for its Reducer product, which was developed to treat refractory angina.
    Read more

  • BSD Medical lands humanitarian device exemption
    BSD Medical Corp. (NSDQ:BSDM) obtained humanitarian device exemption marketing approval for the BSD-2000 Hyperthermia System.
    Read more

  • Dendreon Corp. wins reimbursement approval for Provenge
    Dendreon Corp. (NSDQ:DNDN) today announced the Centers for Medicare & Medicaid Services updated their coverage policy to now cover the infusion costs associated with the administration of Provenge.
    Read more

  • Retina Implant AG plans second human clinical trial
    Retina Implant AG announced that its scientific advisory board is in full support of beginning the multi-center phase of the company’s second human clinical trial for subretinal implants for retinitis pigmentosa patients.
    Read more

  • IsoRay wins State of Wash. approval for GliaSite
    IsoRay Inc. (AMEX: ISR) received final approval from the State of Washington Department of Health to manufacture its GliaSite radiation therapy system, a balloon catheter device used in the treatment of brain cancer.
    Read more

  • Canon touts clearance for radiography detectors
    Canon U.S.A. Inc. announced that the Canon CXDI-80C Wireless Digital Radiography Detector, along with the CXDI-501 Series DR Detectors, received 510(k) clearance.
    Read more

  • CerMed wins CE Mark for CerMap
    CerMed International, an international women’s medical device company, announced that it received CE Mark approval for CerMap, its advanced Cervical Specimen Collection Device used in cervical cancer screening procedures.
    Read more

  • Translational Sciences wins FDA clearance for imaging software
    Translational Sciences Corporation received FDA 510(k) clearance for commercialization of its OncoTrac medical imaging software.
    Read more

  • Merz Aesthetics gets green light for wrinkle treatment
    Merz Aesthetics today announced that the FDA cleared the Belotero Balance device for the correction of moderate-to-severe facial wrinkles and folds.

    Read more

    • In case you missed it

    RSS From Medical Design & Outsourcing

    • DeviceTalks Boston 2022: Here’s what you missed on the show floor
      At DeviceTalks Boston 2022, there was a wealth of expertise to be had from exhibitors including Viant, ICS, PSN Labs, Propel and more. From stories of overcoming challenges during the COVID-19 pandemic to medical device materials pitfalls to avoid, MassDevice and MDO executive editor Chris Newmarker hit the DeviceTalks Boston show floor to discover insights. […]
    • Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future
      All eyes are on Medtronic’s global operations and supply chain leader as he works to modernize its operations and scrutinize suppliers. EVP of Global Operations and Supply Chain Greg Smith anticipates fewer suppliers in Medtronic’s future, he said in an interview this week. Smith spoke with DeviceTalks Editorial Director Tom Salemi in his first published… […]
    • CeQur is launching a discreet, convenient ‘wearable insulin pen’
      CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people with diabetes. When it comes to managing diabetes, CeQur wants to make insulin therapy as convenient as possible. For those who prefer to manage their own insulin delivery, the Simplicity device might just do exactly that. Simplicity, a wearable, disposable… […]
    • Meddux opens new facility in Colorado
      Engineering, design, development and manufacturing company Meddux announced that it opened a new facility in Boulder, Colorado. The new, 22,000-square-foot facility doubles the overall square footage from its previous location in Colorado. According to a news release, it helps the company to quadruple its product development area and double its manufacturing footprint. Meddux’s new facility… […]
    • Reducing the Overall Cost of Validation
      By PTI Engineered Plastics Reliable medical devices and equipment are essential for researchers and doctors to accurately diagnose and treat a wide range of diseases. That is why there is such stringent oversight from the FDA to ensure these products meet the necessary requirements and specifications. To ensure compliance with regulators, manufacturers follow installation qualification… […]
    • BBS Automation has a deal to buy medtech supplier Kahle Automation
      BBS Automation said it plans to purchase high-speed automation supplier Kahle Automation to expand its medtech and life sciences business. Kahle will operate as Kahle – a BBS Company, according to a news release from Munich, Germany-based BBS and Lombardy, Italy-based Kahle. The deal is subject to regulatory approval. Terms were not disclosed. Kahle’s co-owners —… […]
    • How safe is health information after the overturning of Roe?
      The U.S. Department of Health and Human Services today issued guidance meant to better protect women’s health information as state abortion bans kick in after the U.S. Supreme Court’s overturning of Roe v. Wade. Despite the HHS actions, women may still wonder whether their health information is entirely safe going forward — a potential challenge… […]
    • Dexcom focuses on early diabetes diagnosis as COVID links emerge
      New evidence is showing that COVID-19 may increase a person’s risk of diabetes, but it could be years until we know for sure. In the meantime, Dexcom (Nasdaq:DXCM) is getting ready, VP of Global Clinical Initiatives Tomas Walker said. Walker recently spoke with Medical Design & Outsourcing to discuss the San Diego-based diabetes device developer’s… […]
    • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
      Blackrock Neurotech and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL) are working together on the first portable brain-computer interface (BCI) to allow patients to participate in research trials from home. A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year. Salt… […]
    • How medical device companies are responding to abortion bans
      Days after the U.S. Supreme Court’s decision to overturn Roe v. Wade’s protection of abortion rights, medical device companies are among those reassuring workers about healthcare access. Corporate communications to employees and the public at large come as trigger laws in nearly half of the states outlaw abortion immediately. Some medtech companies are not using… […]
    • Philips updates on testing results for recalled ventilators
      Royal Philips (NYSE:PHG) says only a small portion of returned respiratory devices displayed the sound abatement foam degradation that sparked a massive recall. Repeated ozone cleaning may have made the problem worse. Those were some of the major takeaways from an update Philips provided today on a comprehensive test and research program it implemented after its… […]

    Leave a Reply